← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $5.7M of Karuna Therapeutics, Inc.

Sold$5,702,098
$228.08Price
25,000Shares
−63%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Tue, Aug 9. Filed Thu, Aug 11, 1:19 PM ET, during the session. Not investment advice.